Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-15-018020
Filing Date
2015-10-02
Accepted
2015-10-02 17:25:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 bota20151001_424b5.htm 424B5 500736
2 bota20151001_424b5img003.jpg GRAPHIC 3601
3 bota20151001_424b5img002.jpg GRAPHIC 3635
4 logo.jpg GRAPHIC 9968
  Complete submission text file 0001437749-15-018020.txt   526117
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-205272 | Film No.: 151141439
SIC: 2836 Biological Products, (No Diagnostic Substances)